Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (67)
2025 (849)
2024 (934)
2023 (918)
2022 (1034)
2021 (1042)
2020 (874)
2019 (789)
2018 (912)
2017 (936)
2016 (881)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (11760)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
NPJ Precis Oncol
JSON
ISSN
2397-768X
ISSN-L
-
IUID
3d4a08fd8a2b4054bfffb378aef9f787
Modified
2025-03-20T11:42:04.345Z
Created
2025-03-20T11:42:04.345Z
Year 2025
PubMed
DOI
Crossref
Patient-specific sequencing panels enable sensitive circulating tumor DNA analysis in rhabdomyosarcoma independent of genetic profile.
Rahmqvist I, Dahlstrand Rudin A, Mellström E, ..., Ståhlberg A, Dalin M
NPJ Precis Oncol
9
(1) 327 [2025-10-21; online 2025-10-21]
PubMed
DOI
Crossref
Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma.
Mañas A, Seger A, Adamska A, ..., Aaltonen K, Bexell D
NPJ Precis Oncol
9
(1) 311 [2025-09-16; online 2025-09-16]
PubMed
DOI
Crossref
Computational pathology annotation enhances the resolution and interpretation of breast cancer spatial transcriptomics data
Li T, Yang Q,
Acs B
, ...,
Chen X
,
Hartman J
NPJ Precis Oncol
9
(1) 310 [2025-09-09; online 2025-09-09]
Camilla Engblom
SciLifeLab Fellow
PubMed
DOI
Crossref
Towards an interpretable deep learning model of cancer.
Nilsson A
,
Meimetis N
,
Lauffenburger DA
NPJ Precis Oncol
9
(1) 46 [2025-02-14; online 2025-02-14]
Avlant Nilsson
DDLS Fellow
Year 2024
PubMed
DOI
Crossref
Delineating functional and molecular impact of ex vivo sample handling in precision medicine.
Struyf N
,
Österroos A
,
Vesterlund M
, ...,
Seashore-Ludlow B
,
Erkers T
NPJ Precis Oncol
8
(1) 38 [2024-02-19; online 2024-02-19]
Year 2023
PubMed
DOI
Crossref
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients.
Åkerlund E, Gudoityte G,
Moussaud-Lamodière E
, ...,
Joneborg U
,
Seashore-Ludlow B
NPJ Precis Oncol
7
(1) 111 [2023-10-31; online 2023-10-31]
Year 2022
PubMed
DOI
Crossref
Reclassifying tumour cell cycle activity in terms of its tissue of origin.
Lundberg A
,
Yi JJJ
, Lindström LS,
Tobin NP
NPJ Precis Oncol
6
(1) 59 [2022-08-20; online 2022-08-20]
Arian Lundberg
DDLS Fellow
Year 2021
PubMed
DOI
Crossref
FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation.
Gultekin O, Gonzalez-Molina J, Hardell E, ...,
Lehti K
, Carlson JW
NPJ Precis Oncol
5
(1) 97 [2021-11-19; online 2021-11-19]
PubMed
DOI
Crossref
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia.
White BS
, Khan SA, Mason MJ, ..., Wennerberg K, Guinney J
NPJ Precis Oncol
5
(1) 71 [2021-07-23; online 2021-07-23]
SciLifeLab Data Centre
Publications
9.5.1